Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
17.11.2017 21:37:00

Respiratory Diseases Diagnostic Testing Market, 2021

NEW YORK, Nov. 17, 2017 /PRNewswire/--This new 366-page report from LeadingMarketResearch.com contains 108 tables and provides analysis of the global respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. 

Read the full report: https://www.reportlinker.com/p03951408

About this Report

This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales forecasts by country and market segment, including:

  • Hospitals
  • Commercial/Private Labs
  • Physician Offices
  • Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test and country. Also, the report:

  • Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
  • Reviews features and operating characteristics of major analyzers used for respiratory disease testing;
  • Profiles key suppliers and potential market entrants developing innovative technologies and products; and
  • Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as LeadingMarketResearch's proprietary data files was conducted.

Contains 366 pages and 108 tables

Read the full report: https://www.reportlinker.com/p03951408

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

 

View original content:http://www.prnewswire.com/news-releases/respiratory-diseases-diagnostic-testing-market-2021-300558961.html

SOURCE Reportlinker

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!